Eversept Partners, LP Absci Corp Transaction History

Eversept Partners, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$2.55 - $4.38 $187,182 - $321,513	-73,405 Reduced 26.9%	199,464 $522,000
Q3 2024 Nov 14, 2024	SELL	$2.97 - $4.49 $156,340 - $236,353	-52,640 Reduced 16.17%	272,869 $1.04 Million
Q2 2024 Aug 14, 2024	BUY	$2.92 - $6.58 $950,486 - $2.14 Million	325,509 New	325,509 $1 Million

145

68.4M

361K

542K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $264M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.